Table of Content

Table of Contents

1. Executive Summary

2. Global Narcolepsy Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Narcolepsy Drug Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Narcolepsy Drug Market by Disease Type
3.3.1: Daytime Extreme Sleepiness
3.3.2: Cataplexia
3.3.3: Others
3.4: Global Narcolepsy Drug Market by Therapeutics Type
3.4.1: Central Nervous System Stimulants
3.4.2: Tricyclic Antidepressants
3.4.3: Sodium Oxybate
3.4.4: Selective Serotonin Reuptake Inhibitor
3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Narcolepsy Drug Market by Region
4.2: North American Narcolepsy Drug Market
4.2.1: North American Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.2.2: North American Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.3: European Narcolepsy Drug Market
4.3.1: European Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.3.2: European Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.4: APAC Narcolepsy Drug Market
4.4.1: APAC Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.4.2: APAC Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others
4.5: ROW Narcolepsy Drug Market
4.5.1: ROW Market by Disease Type: Daytime Extreme Sleepiness, Cataplexia, and Others
4.5.2: ROW Market by Therapeutics Type: Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Narcolepsy Drug Market by Disease Type
6.1.2: Growth Opportunities for the Global Narcolepsy Drug Market by Therapeutics Type
6.1.3: Growth Opportunities for the Global Narcolepsy Drug Market by Region
6.2: Emerging Trends in the Global Narcolepsy Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Narcolepsy Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Narcolepsy Drug Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Arena Pharmaceuticals
7.2: Bioprojet Company
7.3: Graymark Healthcare
7.4: Hikma Pharmaceuticals
7.5: Jazz Pharmaceuticals
7.6: Ligand Pharmaceuticals Incorporated
7.7: Shionogi